Summary

Revenue : 000,000 M USD
Finance : 000,000 M USD
Earning Cap : 000,000 M USD
Invest : 000,000 M USD
R & D : 0000 People
Growth : 00% AGR

DIGDAL CAP

Overview

General Introduction Aiwei Technology Co., Ltd. was established on March 16, 2000, with its headquarters located in Changsha National High tech Industrial Development Zone, Hunan. It is a professional enterprise established in accordance with modern enterprise systems, specializing in the research, development, and production of medical devices, experimental instruments, in vitro diagnostic reagents and consumables, electronic products, remote medical networks, computer software, automatic control equipment, medical auxiliary equipment, and other products A modern high-tech enterprise engaged in sales and related technical services. Based on the "innovation driven development" strategy, the company focuses on the research and development and industrialization of clinical medical testing equipment, in vitro diagnostic reagents, and medical consumables. The independently innovatively developed key common technologies such as "medical microscope morphology inspection automation" are in an international leading position, filling multiple international and domestic technological gaps. The company has grown into an excellent and internationally competitive provider of high-performance medical testing equipment in China. Aiwei Technology has established two wholly-owned subsidiaries both domestically and internationally. Among them, Hunan Aiwei Medical Technology Co., Ltd. is located in the Yuelu Science and Technology Industrial Park in Yuelu District, Changsha, covering an area of 67 acres. It has built a high-performance medical device and in vitro diagnostic reagent consumables research and production base of over 50000 square meters; AVETECHINC, a wholly-owned subsidiary of the United States Aiwei Technology (USA) Co., Ltd. was registered and established in Gaithersburg, Maryland, USA in 2015. The company is a national specialized, refined, and innovative "little giant" enterprise, a national intellectual property demonstration enterprise, a key high-tech enterprise of the National Torch Plan, a national software enterprise, and a national key new product enterprise; Has successively won government awards such as the National Software Industry Gold Award, China Innovation and Entrepreneurship Competition Excellence Award, China Patent Award (twice), Hunan Provincial Patent Award (multiple times), Hunan Provincial Technology Invention Award, Hunan Provincial Science and Technology Progress Award, etc; We have undertaken nearly a hundred national, provincial, and municipal industrial and information technology, science and technology, development and reform, and intellectual property projects. The company has passed certifications for ISO9001 quality management system, ISO13485 medical device quality management system, and GB/T29490 intellectual property management system, and its leading products have passed certifications such as CE and ROHS. The company has applied for more than 200 patents in total; Registered multiple computer software copyrights; In addition, more than 120 international and domestic registered trademarks have been approved. The company has led the development of multiple industry standards, including "Urine Sediment Analyzer" (Digital Imaging Automatic Identification), "Quality Control Materials for Urine Sediment Analyzer", and "Automatic Fecal Analyzer". The company has gathered a group of multi-disciplinary doctoral, master's, undergraduate and other technical talents, and has undertaken the construction of three provincial and ministerial level innovation platforms, including the Hunan Engineering Research Center for Medical Microscope Inspection Automation. The company focuses on the research and development of key technologies and related medical equipment for intelligent medical testing, especially in the field of automatic microscope morphology testing. It has achieved significant technological achievements centered on international cutting-edge "machine vision technology" and "intelligent microscope morphology testing technology", achieving high-speed visualization of microscopic images of tangible pathological components in clinical urine, blood, feces, bodily fluids, gynecological secretions, and other specimens, Intelligent recognition, classification, and quantitative counting have put an end to the history of microscopic examination that can only be completed manually, filling the gap in automatic microscopic examination technology for international and domestic microscopic morphology. At present, the company has established offices in 30 provincial-level administrative regions across the country, with over 4000 installed users and a domestic market share of nearly 40%; Internationally, the products have been exported to countries and regions such as Europe, the Americas, and Asia. The company will continue to adhere to the core concept of "technology services for health", with the business purpose of "creating results, realizing value, long-term survival, and common development". Through independent research and development, integrating the most advanced technology at home and abroad, adopting advanced production processes, the company is committed to the research, development, and industrialization of medical equipment, experimental instruments, in vitro diagnostic reagents, consumables, etc., so as to grow into a respected high-performance medical device research and development both internationally and domestically A benchmark enterprise in the manufacturing and healthcare service industries, striving to achieve the beautiful vision of "enabling everyone to enjoy modern healthcare services".
Headquarter Changsha
Establish Date 3/16/2000
Listed Code 688067.SH
Listed Date 6/16/2021
Chairman Ding Jianwen.
CEO Ding Jianwen.
Website www.c-ave.com

Buy Premium Now

$15/month billed now

View the full stack of insights immediately

Or 7 Days Free Charge for Trial

See feature available in the Trial and Premium

See our Solution and Servicetrial.solutionservice.trial

See our Uniquness and Value deliveringtrial.solutionservice.trial